We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$49.9B
AUM Growth
+$585M
Cap. Flow
-$2.78B
Cap. Flow %
-5.57%
Top 10 Hldgs %
36.03%
Holding
1,025
New
73
Increased
356
Reduced
366
Closed
173

Sector Composition

Rank Sector Weight
1 Technology 24.25%
2 Healthcare 15.8%
3 Consumer Discretionary 14.05%
4 Communication Services 13.59%
5 Financials 12.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INSP icon
76
Inspire Medical Systems
INSP
$1.74B
$71.6M 0.14%
284,353
-6,797
-2% -$1.45M
FCN icon
77
FTI Consulting
FCN
$4.18B
$71.4M 0.14%
449,599
-3,936
-0.9% -$657K
AIN icon
78
Albany International
AIN
$1.78B
$70.9M 0.14%
719,271
-14,255
-2% -$1.36M
HXL icon
79
Hexcel
HXL
$7.82B
$70.7M 0.14%
1,201,357
+137,131
+13% +$7.85M
ZION icon
80
Zions Bancorporation
ZION
$10.3B
$70.7M 0.14%
+1,438,015
New +$71.9M
KNSL icon
81
Kinsale Capital Group
KNSL
$8.51B
$68.6M 0.14%
262,130
+17,425
+7% +$5.02M
CNMD icon
82
CONMED
CNMD
$1.47B
$67M 0.13%
755,316
-10,734
-1% -$891K
AEIS icon
83
Advanced Energy
AEIS
$13B
$64.7M 0.13%
754,074
+32,698
+5% +$2.75M
WNS
84
DELISTED
WNS Holdings
WNS
$63.4M 0.13%
792,792
-18,961
-2% -$1.56M
MGY icon
85
Magnolia Oil & Gas
MGY
$5.94B
$62.9M 0.13%
2,683,018
+633,263
+31% +$15.4M
HLNE icon
86
Hamilton Lane
HLNE
$5.57B
$61.1M 0.12%
955,898
-12,414
-1% -$826K
CHDN icon
87
Churchill Downs
CHDN
$6.12B
$59.6M 0.12%
564,076
+26,096
+5% +$2.75M
VUG icon
88
Vanguard Morningstar Growth ETF
VUG
$230B
$58.1M 0.12%
1,636,482
+1,311,132
+403% +$48.2M
MMSI icon
89
Merit Medical Systems
MMSI
$5.32B
$57.9M 0.12%
819,655
-19,603
-2% -$1.31M
WHD icon
90
Cactus
WHD
$5.44B
$57.1M 0.11%
1,136,682
-27,184
-2% -$1.36M
PCRX icon
91
Pacira BioSciences
PCRX
$997M
$56.8M 0.11%
1,471,918
+33,177
+2% +$1.61M
ABEV icon
92
Ambev
ABEV
$46.4B
$56.4M 0.11%
20,741,732
-712,929
-3% -$2.08M
UTHR icon
93
United Therapeutics
UTHR
$23.1B
$56.3M 0.11%
202,458
-1,007
-0.5% -$254K
COLM icon
94
Columbia Sportswear
COLM
$2.94B
$56.3M 0.11%
642,463
-7,158
-1% -$576K
MTSI icon
95
MACOM Technology Solutions
MTSI
$23.7B
$56M 0.11%
889,574
-21,278
-2% -$1.33M
CALX icon
96
Calix
CALX
$2.39B
$55.8M 0.11%
815,409
-19,503
-2% -$1.31M
SUPN icon
97
Supernus Pharmaceuticals
SUPN
$2.77B
$55.6M 0.11%
1,559,535
-41,768
-3% -$1.45M
SITE icon
98
SiteOne Landscape Supply
SITE
$4.53B
$55.6M 0.11%
473,507
-5,218
-1% -$608K
MGRC icon
99
McGrath RentCorp
MGRC
$2.92B
$54.8M 0.11%
555,408
-16,382
-3% -$1.53M
EVH icon
100
Evolent Health
EVH
$447M
$53.8M 0.11%
1,916,283
-712,701
-27% -$20.4M

Similar funds

Loomis, Sayles & Company's Q4 2022 Portfolio in Review

As of Q4 2022, Loomis, Sayles & Company held 1,025 positions worth $49.9B, up 1.2% from $49.4B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Loomis, Sayles & Company withdrew a net $2.78B in Q4 2022, closing 173 positions and reducing 366 holdings. Its most notable exit was TechTarget, an estimated $41M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Loomis, Sayles & Company opened a new position in Zions Bancorporation worth $70.7M.

  • Loomis, Sayles & Company's largest Q4 2022 buy was Zions Bancorporation: 1,438,015 shares worth $70.7M.
  • Loomis, Sayles & Company added most to Tesla in Q4 2022, an estimated $644M increase.
  • Loomis, Sayles & Company's biggest Q4 2022 reduction was Deere & Co, cutting an estimated $435M.
  • Loomis, Sayles & Company fully exited TechTarget in Q4 2022, selling an estimated $41M.
  • Loomis, Sayles & Company's ten largest holdings make up 36% of its $49.9B portfolio in Q4 2022.
  • Loomis, Sayles & Company opened 73 new positions and closed 173 in Q4 2022.
  • Loomis, Sayles & Company's portfolio value rose 1.2% quarter-over-quarter to $49.9B.

Based on Loomis, Sayles & Company's 13F filing for Q4 2022, filed 10 Feb 2023.